In this fifth installment, Shubham Pant, MD, and Tanios Bekaii-Saab, MD, discuss the best practices for treating adverse events associated with treatments such as FOLFIRINOX or NALIRIFOX.

Read More ›

In this fourth installment, Shubham Pant, MD, along with Tanios Bekaii-Saab, MD, discuss the key side effects seen in clinical trials of first-line treatments for patients with pancreatic cancer. Read More ›

In this third installment, Michael Pishvaian, MD, PhD, and Tanios Bekaii-Saab, MD, discuss why median progression-free survival is so important when considering the various transformational trials in pancreatic cancer. Read More ›

In this second installment, Shubham Pant, MD, along with Tanios Bekaii-Saab, MD, discuss various first-line treatments for metastatic pancreatic ductal adenocarcinoma from the MPACT, PRODIGE-4, and NAPOLI 3 trials. Read More ›

In this first installment, Shubham Pant, MD, along with Tanios Bekaii-Saab, MD, discuss how patients are evaluated for pancreatic cancer. Read More ›

Successfully getting patients with multiple myeloma to follow their therapy regimen often requires a team approach. Please join Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, as they outline which team members they utilize and how they use this technique at their institutions. Read More ›

Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, discuss how they use shared decision-making with patients to help them remain adherent to their treatment plan. Read More ›

Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, talk about the clues and the patient characteristics that they use to determine which of their patients with multiple myeloma may be at risk for not adhering to their anticancer therapy. Read More ›

Patients with multiple myeloma often face a difficult road in their cancer journey because of their treatment regimen. Please join Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, as they share some of their best practices for keeping patients on therapy. Read More ›

Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, break down the misconceptions that patients with multiple myeloma may have about the different treatment regimens and how those misconceptions can affect their views on treatment adherence. Read More ›